[Featured Stock] Shinshin Pharmaceutical Rises on Selection as Major Contractor for US Federal Government

[Asia Economy Reporter Minji Lee] Shinshin Pharmaceutical is showing a sharp rise after news spread that it has entered the procurement market of the U.S. Department of Veterans Affairs.

At 10:55 AM on the 17th, Shinshin Pharmaceutical was trading at 7,080 KRW on the KOSDAQ market, up 26.43% from the previous session.

The day before, Shinshin Pharmaceutical became the first domestic healthcare company to sign an e-commerce contract with the U.S. Department of Veterans Affairs. Accordingly, Shinshin Pharmaceutical registered eight topical anti-inflammatory and analgesic products, including Shinshin Pas Arex, with over 600 U.S. Department of Veterans Affairs hospital facilities and the U.S. General Services Administration's e-commerce shopping mall, GSA Advantage.